The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Prakhar Agrawal's Stock Ratings
Cantor Fitzgerald Analyst
Prakhar Agrawal is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
13.8%
Smart Score
Overall Average Return Percentile
66th
Number of Ratings
71
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/10/2025 | AKRO | Buy Now | Akero Therapeutics | $54.70 | — | — | Suspends | Overweight → Overweight | Get Alert | |
| 12/01/2025 | EVMN | Buy Now | Evommune | $18.59 | — | — | Initiates | → Overweight | Get Alert | |
| 11/05/2025 | MDGL | Buy Now | Madrigal Pharmaceuticals | $563.64 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 09/03/2025 | MTSR | Buy Now | Metsera | — | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 08/15/2025 | AVTX | Buy Now | Avalo Therapeutics | $18.50 | — | — | Initiates | → Overweight | Get Alert | |
| 06/23/2025 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/06/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 04/23/2025 | TVTX | Buy Now | Travere Therapeutics | $35.80 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 04/03/2025 | TVTX | Buy Now | Travere Therapeutics | $35.80 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 03/18/2025 | ACRS | Buy Now | Aclaris Therapeutics | $3.27 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 02/25/2025 | MTSR | Buy Now | Metsera | — | — | — | Initiates | → Overweight | Get Alert | |
| 02/21/2025 | TVTX | Buy Now | Travere Therapeutics | $35.80 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 01/21/2025 | KROS | Buy Now | Keros Therapeutics | $20.90 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 01/14/2025 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Reiterates | Overweight → Overweight | Get Alert | |
| 01/06/2025 | ATYR | Buy Now | aTyr Pharma | $0.76 | — | — | Initiates | → Overweight | Get Alert | |
| 12/17/2024 | TLSI | Buy Now | TriSalus Life Sciences | $7.10 | 40.85% | → $10 | Initiates | → Overweight | Get Alert | |
| 11/22/2024 | KROS | Buy Now | Keros Therapeutics | $20.90 | — | — | Reiterates | → Overweight | Get Alert | |
| 11/20/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $563.64 | — | — | Reiterates | → Neutral | Get Alert | |
| 10/24/2024 | KROS | Buy Now | Keros Therapeutics | $20.90 | — | — | Reiterates | → Overweight | Get Alert | |
| 10/11/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $563.64 | — | — | Reiterates | → Neutral | Get Alert | |
| 09/23/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/23/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/23/2024 | MLTX | Buy Now | MoonLake | $14.56 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/16/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/09/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/09/2024 | MLTX | Buy Now | MoonLake | $14.56 | — | — | Reiterates | → Overweight | Get Alert | |
| 09/09/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/19/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/15/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 07/23/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $563.64 | — | — | Reiterates | → Neutral | Get Alert | |
| 07/01/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/28/2024 | MDGL | Buy Now | Madrigal Pharmaceuticals | $563.64 | — | — | Initiates | → Neutral | Get Alert | |
| 06/20/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Reiterates | → Overweight | Get Alert | |
| 06/20/2024 | AKRO | Buy Now | Akero Therapeutics | $54.70 | — | — | Reiterates | → Overweight | Get Alert | |
| 06/20/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/17/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 06/12/2024 | AKRO | Buy Now | Akero Therapeutics | $54.70 | — | — | Reiterates | → Overweight | Get Alert | |
| 06/03/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 05/28/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Reiterates | → Overweight | Get Alert | |
| 05/03/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/18/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | $65 → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 04/09/2024 | GPCR | Buy Now | Structure Therapeutics | $67.92 | -4.3% | → $65 | Initiates | → Overweight | Get Alert | |
| 02/23/2024 | ORIC | Buy Now | ORIC Pharmaceuticals | $9.43 | — | — | Initiates | → Overweight | Get Alert | |
| 02/20/2024 | RAPT | Buy Now | RAPT Therapeutics | $35.72 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 11/08/2023 | MLTX | Buy Now | MoonLake | $14.56 | 435.71% | → $78 | Reiterates | Overweight → Overweight | Get Alert | |
| 10/11/2023 | AKRO | Buy Now | Akero Therapeutics | $54.70 | -28.7% | $69 → $39 | Maintains | Overweight | Get Alert | |
| 10/04/2023 | AKRO | Buy Now | Akero Therapeutics | $54.70 | 26.14% | → $69 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/19/2023 | AKRO | Buy Now | Akero Therapeutics | $54.70 | 26.14% | → $69 | Initiates | → Overweight | Get Alert | |
| 09/18/2023 | MLTX | Buy Now | MoonLake | $14.56 | 346.43% | → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/14/2023 | MLTX | Buy Now | MoonLake | $14.56 | 346.43% | → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 09/12/2023 | MLTX | Buy Now | MoonLake | $14.56 | 346.43% | → $65 | Reiterates | Overweight → Overweight | Get Alert | |
| 08/15/2023 | CBAY | Buy Now | CymaBay Therapeutics | — | — | $13 → $15 | Maintains | Buy | Get Alert | |
| 07/03/2023 | MLTX | Buy Now | MoonLake | $14.56 | 346.43% | $29 → $65 | Maintains | Overweight | Get Alert | |
| 06/20/2023 | DICE | Buy Now | DICE Therapeutics | — | — | $58 → $48 | Downgrade | Overweight → Neutral | Get Alert | |
| 04/17/2023 | TGTX | Buy Now | TG Therapeutics | $31.41 | -23.59% | → $24 | Reiterates | → Overweight | Get Alert | |
| 03/20/2023 | MLTX | Buy Now | MoonLake | $14.56 | 99.18% | $23 → $29 | Maintains | Overweight | Get Alert | |
| 03/06/2023 | MLTX | Buy Now | MoonLake | $14.56 | 57.97% | → $23 | Reiterates | → Overweight | Get Alert | |
| 02/14/2023 | MLTX | Buy Now | MoonLake | $14.56 | 57.97% | → $23 | Initiates | → Overweight | Get Alert | |
| 02/07/2023 | TGTX | Buy Now | TG Therapeutics | $31.41 | -23.59% | $18 → $24 | Maintains | Overweight | Get Alert | |
| 02/03/2023 | SPPI | Buy Now | Spectrum Pharma | — | — | $3 → $0.75 | Maintains | Neutral | Get Alert | |
| 09/14/2022 | DICE | Buy Now | DICE Therapeutics | — | — | → $36 | Initiates | → Overweight | Get Alert | |
| 07/15/2022 | TCRT | Buy Now | Alaunos Therapeutics | $4.23 | -29.13% | → $3 | Assumes | → Overweight | Get Alert | |
| 06/13/2022 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | → $21 | Assumes | → Overweight | Get Alert | |
| 05/24/2022 | RAPT | Buy Now | RAPT Therapeutics | $35.72 | 23.18% | → $44 | Assumes | → Overweight | Get Alert | |
| 09/23/2021 | LABP | Buy Now | Landos Biopharma | — | — | → $39 | Initiates | → Buy | Get Alert | |
| 06/14/2021 | CBAY | Buy Now | CymaBay Therapeutics | — | — | → $8 | Initiates | → Buy | Get Alert | |
| 05/18/2021 | LIFE | Buy Now | aTyr Pharma | — | — | → $15 | Initiates | → Buy | Get Alert | |
| 03/29/2021 | OCUP | Buy Now | Ocuphire Pharma | — | — | → $20 | Initiates | → Buy | Get Alert | |
| 03/03/2021 | EQ | Buy Now | Equillium | $1.33 | 952.63% | → $14 | Initiates | → Buy | Get Alert | |
| 11/19/2020 | FMTX | Buy Now | Forma Therapeutics Hldgs | — | — | → $61 | Initiates | → Overweight | Get Alert | |
| 03/04/2020 | ZIOP | Buy Now | ZIOPHARM Oncology | — | — | → $6 | Initiates | → Overweight | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved